Cancer plaintiffs drill down on J&J's support for $8.9 billion talc deal

The lead negotiators for Johnson & Johnson's proposed $8.9 billion settlement of thousands of talc lawsuits faced intense questioning in US Bankruptcy court on Wednesday about how much support the company has for the deal.